Skip to content

Cost-effectiveness of minimal invasive spinal fusion compared to open fusion for patients with spinal stenosis with neurogenic claudication or radicular leg pain.

Cost-effectiveness of minimal invasive spinal fusion compared to open fusion for patients with spinal stenosis with neurogenic claudication or radicular leg pain.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23242
Enrollment
340
Registered
2014-07-21
Start date
2014-06-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Included are patients with neurogenic claudication or radicular leg pain due to spinal stenosis which do not respond to conservative therapy for at least 6 months.

Interventions

Intervention: The intervention arm will be minimal invasive surgery with decompression through a small incision and a computer assisted fusion with an interbody fusion device and posterior instrument

Sponsors

Leiden University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A subject must meet all of the following criteria: - Neurogenic claudication or radicular leg pain. - Complaints are due to MRI confirmed existence of lytic or degenerative Spondylolisthesis of maximal 50% or Meyerding Grade II, or spinal stenosis, at one or two levels. - Spine is expected to destabilize after simple lumbar decompressive surgery. - Single or double level fusion indicated. - Insufficient response to conservative therapy (physical therapy, analgesic medications, or trans-foraminal corticosteroid injections) for at least 6 months. - Age is between and including 18-70 years. - Be able to understand the Dutch language and comprehend the questionnaires and patient information. - Patients signed informed consent.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded: - Iatrogenic Spondylolisthesis or more than 50% or more than Meyerding Grade II. - Inflammatory arthritis, Osteoporosis or other metabolic bone disease to a degree that it would influence fusion. - Contraindication for surgery.

Design outcomes

Primary

MeasureTime frame
The primary outcome parameter is speed of recovery on Oswestry Disability Index (ODI).

Secondary

MeasureTime frame
Secondary outcome parameters are ODI, cost (Cost intervention, postoperative health care use, and loss of productivity), VAS leg pain, VAS back pain, transformed Quality of Life VAS, Quality-Adjusted-Life Years (QALY) based on measured EuroQol (EQ-5D), ZCQ, Likert perceived recovery patient, Likert perceived recovery care provider, SF36, complications, operative morbidity (scar length, muscle damage assessed with CRP values), and fusion.

Contacts

Public ContactW.C.H. Jacobs
w.c.h.jacobs@lumc.nl071-5261490

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)